REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 438 filers reported holding REPLIGEN CORP in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,880,000 | +92.9% | 20,734 | +67.5% | 0.23% | +55.0% |
Q2 2022 | $2,011,000 | -26.6% | 12,382 | -15.0% | 0.15% | -15.6% |
Q1 2022 | $2,739,000 | +43.1% | 14,562 | +101.5% | 0.18% | -25.1% |
Q4 2021 | $1,914,000 | -19.5% | 7,226 | -12.2% | 0.24% | -24.4% |
Q3 2021 | $2,378,000 | +555.1% | 8,230 | +352.4% | 0.32% | +159.0% |
Q2 2021 | $363,000 | -81.7% | 1,819 | -82.2% | 0.12% | -80.8% |
Q1 2021 | $1,986,000 | +84.7% | 10,216 | +82.1% | 0.64% | +106.8% |
Q4 2020 | $1,075,000 | -31.8% | 5,611 | -72.7% | 0.31% | -47.8% |
Q3 2019 | $1,576,000 | -16.5% | 20,550 | -6.4% | 0.59% | -15.6% |
Q2 2019 | $1,887,000 | +0.6% | 21,952 | -30.9% | 0.70% | -35.0% |
Q1 2019 | $1,876,000 | +37.4% | 31,762 | +22.7% | 1.07% | +181.4% |
Q4 2018 | $1,365,000 | +693.6% | 25,876 | +105.5% | 0.38% | +728.3% |
Q4 2013 | $172,000 | -74.4% | 12,590 | -79.2% | 0.05% | -76.2% |
Q3 2013 | $672,000 | +34.4% | 60,620 | 0.0% | 0.19% | +24.5% |
Q2 2013 | $500,000 | – | 60,620 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |